- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Hageman receives Lighthouse Award
Gregory Hageman, PhD, has been selected for the 2011 Lighthouse International Pisart Vision Award. Presented annually, this award honors an individual who has “distinguished himself or herself by invention or otherwise in the prevention, cure, treatment, or care of blindness.”
Salt Lake City-Gregory Hageman, PhD, has been selected for the 2011 Lighthouse International Pisart Vision Award. Presented annually, this award honors an individual who has “distinguished himself or herself by invention or otherwise in the prevention, cure, treatment, or care of blindness.”
The $30,000 award will be presented to Dr. Hageman, professor of ophthalmology and visual sciences at the University of Utah and director of the John A. Moran Center for Translational Medicine, in New York City on Jan. 19.
Over the past two decades, Dr. Hageman has made significant advances in knowledge about age-related macular degeneration (AMD). When he arrived at the John A. Moran Eye Center in 2009, he brought what is believed to be the largest human donor eye tissue repository in the world. With more than 4,500 pairs of human eyes, the repository plays a critical role in breakthrough discoveries related to AMD and other ocular and systemic diseases. Through these donated eyes, Dr. Hageman and his colleagues have made hallmark contributions to the understanding of AMD genetics.
For more articles in this issue of Ophthalmology Times eReport, click here.
